Anaergia Reports Delay in Submission of Audited Financial Statements and Related Disclosures

Reading Time: < 1 minute

Anaergia Inc. Faces Delay in Filing Annual Financial Statements

BURLINGTON, Ontario, March 29, 2024– Anaergia Inc. (Anaergia) announced today that there will be a delay in the filing of its annual information form for the year ended December 31, 2023, audited annual consolidated financial statements for the year ended December 31, 2023, and other related documents beyond the April 1, 2024, filing deadline.

Reasons for Delay

The delay in filing the required documents is due to the restructuring activities and transformation of the company during the 2023 year, causing delays in the financial reporting process. Anaergia is working with Deloitte LLP to complete the audit of the annual consolidated financial statements and expects to file the documents by April 15, 2024.

Consequences of Delay

The Ontario Securities Commission (OSC) is likely to impose a failure to file cease trade order (CTO) under National Policy 11-207. This order would prohibit trading of Anaergia’s securities in Canada until the required documents are filed.

Company’s Response

Anaergia will issue bi-weekly default status reports as per the alternative information guidelines under NP 12-203 until the filing requirements are met. The company confirms that there are no insolvency proceedings and is up to date with its other filing obligations.

About Anaergia

Anaergia specializes in converting organic waste into renewable natural gas, fertilizer, and water using proprietary technologies. The company aims to reduce greenhouse gas emissions and provide sustainable solutions for resource recovery challenges.

Forward-Looking Statements

The company acknowledges the risks and uncertainties associated with the delay in filing the required documents and trading restrictions. Anaergia will continue to update stakeholders as required by applicable securities laws.

For further information, visit www.anaergia.com.

Contact Information

For media and investor relations inquiries, please contact IR@Anaergia.com.